From WashingtonPost.com: Ten years ago, many experts thought you couldn’t bring antiretroviral therapy to people with AIDS in poor countries. The drugs cost too much, there weren’t enough doctors, the patients wouldn’t take the medicines correctly, and the risk of creating a resistant virus was too high.
